Antiviral chemotherapy.
D000225:Adenine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001089:Arabinose / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D009705:Nucleosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D013045:Species Specificity; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D007211:Indoles; D009705:Nucleosides; D013882:Thiosemicarbazones; D003561:Cytarabine; D007372:Interferons; D001089:Arabinose; D000547:Amantadine; D000225:Adenine; D007065:Idoxuridine; D011070:Poly I-C